Anthony Jarkowski

Anthony Jarkowski

UNVERIFIED PROFILE

Are you Anthony Jarkowski?   Register this Author

Register author
Anthony Jarkowski

Anthony Jarkowski

Publications by authors named "Anthony Jarkowski"

Are you Anthony Jarkowski?   Register this Author

19Publications

423Reads

16Profile Views

Immunotherapy in Melanoma: Recent Advances and Promising New Therapies.

J Pharm Pract 2015 Apr 27;28(2):193-203. Epub 2014 Mar 27.

Department of Pharmacy, University of Rochester Medical Center, Rochester, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0897190014527317DOI Listing
April 2015

Controversies in the management of advanced melanoma: "gray" areas amid the "black and blue".

Ann Pharmacother 2014 Nov 23;48(11):1456-68. Epub 2014 Jul 23.

The University of Texas MD Anderson Cancer Center, Houston, TX, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1060028014544165DOI Listing
November 2014

Retrospective analysis of the safety and efficacy of high-dose interleukin-2 after prior tyrosine kinase inhibitor therapy in patients with advanced renal cell carcinoma.

J Immunother 2014 Sep;37(7):360-5

Departments of *Medicine, Division of Medical Oncology **Biostatistics ††Pharmacy, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO ‡Department of Medicine, Division of Medical Oncology, University of Southern California, Los Angeles, CA §Roswell Park Cancer Institute ‡‡Department of Pharmacy, Roswell Park Cancer Institute, Buffalo, NY ∥Department of Medicine, Division of Medical Oncology, University of Utah Huntsman Cancer Institute, Salt Lake City, UT ¶Department of Medicine, Division of Medical Oncology, University of Michigan, Ann Arbor, MI #Department of Medicine, Division of Medical Oncology, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN †Department of Medicine, Division of Medical Oncology, The Ohio State University Wexner Medical Center, Columbus, OH §§Department of Medicine, Division of Medical Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL.

View Article

Download full-text PDF

Source
http://is.muni.cz/do/rect/habilitace/1411/Puzanov/habilitace
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/CJI.0000000000000044DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127096PMC
September 2014

BRAF and beyond: Tailoring strategies for the individual melanoma patient.

J Carcinog 2014 7;13. Epub 2014 Feb 7.

Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/1477-3163.126759DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986540PMC
June 2014

Dose rounding of ipilimumab in adult metastatic melanoma patients results in significant cost savings.

J Oncol Pharm Pract 2014 Feb 19;20(1):47-50. Epub 2013 Mar 19.

James P Wilmot Cancer Center at the University of Rochester Medical Center, Rochester, NY, USA.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/1078155213476723
Publisher Site
http://dx.doi.org/10.1177/1078155213476723DOI Listing
February 2014

A new era for castrate resistant prostate cancer: a treatment review and update.

J Oncol Pharm Pract 2012 Sep 16;18(3):343-54. Epub 2012 Feb 16.

Roswell Park Cancer Institute, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155212437599DOI Listing
September 2012

Characterization of vancomycin pharmacokinetics in the adult acute myeloid leukemia population.

J Oncol Pharm Pract 2012 Mar 26;18(1):91-6. Epub 2011 Apr 26.

Department of Pharmacy, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155211402107DOI Listing
March 2012

Treatment of concurrent metastatic renal cell carcinoma and chronic myelogenous leukemia--easier said than done? A case report.

J Oncol Pharm Pract 2011 Dec 16;17(4):436-9. Epub 2010 Sep 16.

Department of Pharmacy, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155210382060DOI Listing
December 2011

Case report of pneumatosis intestinalis secondary to sunitinib treatment for refractory gastrointestinal stromal tumor.

Anticancer Res 2011 Oct;31(10):3429-32

Department of Pharmacy, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
October 2011

Heart failure caused by molecularly targeted therapies for cancer.

Pharmacotherapy 2011 Jan;31(1):62-75

Department of Pharmacy, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1592/phco.31.1.62
Publisher Site
http://dx.doi.org/10.1592/phco.31.1.62DOI Listing
January 2011

Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing.

Pharmacotherapy 2010 Dec;30(12):1279-91

Laboratory for Antimicrobial Pharmacodynamics, School of Pharmacy and Pharmaceutical Sciences Buffalo, and The New York State Center of Excellence in Bioinformatics and Life Sciences, University at Buffalo, Buffalo, New York 14260, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1592/phco.30.12.1279DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410713PMC
December 2010

Bendamustine: a new treatment option for chronic lymphocytic leukemia.

Pharmacotherapy 2009 Nov;29(11):1375-84

Department of Pharmacy, Medical University of South Carolina, Charleston, SC 29412, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1592/phco.29.11.1375DOI Listing
November 2009

Response to sorafenib after sunitinib-induced acute heart failure in a patient with metastatic renal cell carcinoma: case report and review of the literature.

Pharmacotherapy 2009 Apr;29(4):473-8

Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1592/phco.29.4.473DOI Listing
April 2009

Possible contribution of aprepitant to ifosfamide-induced neurotoxicity.

Am J Health Syst Pharm 2008 Dec;65(23):2229-31

Hematology/Oncology, Department of Pharmacy, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2146/ajhp080069DOI Listing
December 2008

Nilotinib: a new tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia.

Pharmacotherapy 2008 Nov;28(11):1374-82

Department of Pharmacy, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1592/phco.28.11.1374DOI Listing
November 2008